Dermapharm Holding SE

FSX:DMP.DE

35.1 (EUR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

20232022202120202019201820172016201520142013
Assets:
Current Assets:
Cash & Cash Equivalents 158.724149.918160.319120.623114.98212.816.2863.8162.79111.6454.665
Short Term Investments 0.78311.4411.7421.0371.0561.1010.40.030.0290.120.12
Cash and Short Term Investments 158.724161.358172.061121.66116.036213.9116.6863.8162.79111.6454.665
Net Receivables 140.113117.163104.17970.57164.28241.127104.76368.07662.14284.224108.513
Inventory 320.758251.822240.535203.264172.167115.5681.10684.58276.91271.14667.516
Other Current Assets 10.9013.6042.4474.5570.4560.640.3150.4850.2591.5231.208
Total Current Assets 630.496533.947519.222400.052352.941371.238192.87156.959142.104168.538181.902
Non-Current Assets:
Property, Plant & Equipment, Net 330.77225.673222.287199.619132.58580.87456.03653.35753.40656.54757.352
Goodwill 578.521271.319264.73266.268202.24454.62124.58317.03316.44421.55326.743
Intangible Assets 544.86305.043294.841297.342293.03189.934133.40470.02567.96671.71370.315
Goodwill and Intangible Assets 1,123.381576.362559.571563.61495.274244.555157.98787.05884.4193.26697.058
Long Term Investments 75.34565.41494.14760.07963.0146.7737.7214.07716.68911.17413.073
Tax Assets 22.83211.44001.0560.0390.290.2180.0280.9520.472
Other Non-Current Assets 0.6810.00111.7421.0370.0011.1020.40.030.0290.120.12
Total Non-Current Assets 1,553.009878.89887.747824.345691.93333.343222.433154.74154.562162.059168.075
Total Assets 2,183.5051,412.8361,406.9691,224.3961,044.871704.581415.303311.699296.666330.597349.977
Liabilities & Equity:
Current Liabilities:
Account Payables 86.64156.152.10150.3735.35528.18123.36724.52618.13927.44925.378
Short Term Debt 116.434.8875.5826.04411.26371.57732.26465.88324.90620.38252.118
Tax Payables 81.818110.74960.19414.56213.34427.455.9457.853.8085.4341.531
Deferred Revenue 0.942155.34196.61254.78350.26345.26724.19924.39517.82348.15389.327
Other Current Liabilities 190.4761.4641.321.6755.541.3730.7460.6190.7051.0531.837
Total Current Liabilities 394.489217.792155.613132.872102.421146.39880.576115.42361.57397.037168.66
Non-Current Liabilities:
Long Term Debt 950.705511.561574.721580.759543.347232.743222.48396.896151.073161.53100.831
Deferred Revenue Non-Current 11.6859.2049.456145.01475.66-137.43717.50923.71426.1300
Deferred Tax Liabilities Non-Current 135.21750.51836.05629.94827.0384.45211.0263.3650.19100
Other Non-Current Liabilities 134.67691.269131.28911.22111.915202.3410.02411.49513.25738.0239.125
Total Non-Current Liabilities 1,232.283662.552751.522766.942657.96302.098261.042135.47190.651199.55139.956
Total Liabilities 1,626.772880.344907.135899.814760.381448.496341.618250.893252.224296.587308.616
Equity:
Preferred Stock 0009.7467.012000000
Common Stock 53.8453.8453.8453.8453.8453.840.121.3421.3421.3421.342
Retained Earnings 367.223355.357337.954177.082139.067100.99325.66956.27439.45728.61633.911
Accumulated Other Comprehensive Income/Loss 17.35421.6054.732-9.746-7.012-90.65-50.644-45.052-41.515-40.226-39.204
Other Total Stockholders Equity 100.79100.79100.7991.04485.742188.26698.5444.35141.81838.54439.454
Total Shareholders Equity 539.207531.592497.316321.966278.649252.44973.68556.91541.10228.27635.503
Total Equity 545.048532.492499.834324.582284.49256.08573.68560.80644.44234.0141.361
Total Liabilities & Shareholders Equity 2,183.5051,412.8361,406.9691,224.3961,044.871704.581415.303311.699296.666330.597349.977